ENDOcare plans 1997 trial for urinary stent:
This article was originally published in Clinica
Executive Summary
ENDOcare says it plans to start trials of its nitinol urinary stent in 1997. The stent is designed for temporary relief of obstructions. ENDOcare says stenting overcomes the limitations that urinary catheters place on the lifestyle of those who use them, while the shape-memory properties of the nitinol alloy will reduce the trauma of removal.
You may also be interested in...
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.